FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911734644> ?p ?o ?g. }

• W2911734644 endingPage "114" @default.
• W2911734644 startingPage "106" @default.
• W2911734644 abstract "<b><i>Background:</i></b> Etelcalcetide is a novel second-generation calcimimetic that, because of its intravenous administration, could improve treatment adherence in secondary hyperparathyroidism (SHPT). The aim of this study was to evaluate the effectiveness of etelcalcetide compared with that of cinacalcet in controlling SHPT in patients under hemodialysis. <b><i>Methods:</i></b> A prospective observational study was performed in 29 patients with SHPT under hemodialysis who switched from cinacalcet to etelcalcetide with a follow-up of 6 months. A survey was conducted of adherence to the oral calcimimetic. The primary end-point of the study was to assess whether etelcalcetide was more effective than cinacalcet in controlling SHPT. <b><i>Results:</i></b> After the switch of treatment, none of the patients developed clinical intolerance or new adverse effects. Etelcalcetide was more effective than cinacalcet in controlling intact parathyroid hormone (iPTH), with an overall decrease in iPTH levels that was significant from the second month. Average calcium levels remained within the normal range, with a higher percentage of hypocalcemia with etelcalcetide (6.9 vs. 13.8%), which was asymptomatic in all cases. Patients who were nonadherent to cinacalcet (38%) showed a significant reduction in calcium and iPTH during follow-up with etelcalcetide. The adherent group (62%) also showed a trend to lower iPTH levels reaching statistical significance after 5 months of follow-up. The dose conversion factor for the switch from cinacalcet to etelcalcetide was etelcalcetide/session = 0.111*mg cinacalcet/day + 0.96, <i>R</i>² = 0.57. <b><i>Conclusions:</i></b> Etelcalcetide was more effective than cinacalcet in this patient population, especially in the nonadherent subgroup, leading to better SHPT control without adverse effects." @default.
• W2911734644 created "2019-02-21" @default.
• W2911734644 creator A5005436555 @default.
• W2911734644 creator A5022120521 @default.
• W2911734644 creator A5025983976 @default.
• W2911734644 creator A5032023728 @default.
• W2911734644 creator A5033938377 @default.
• W2911734644 creator A5038723740 @default.
• W2911734644 creator A5041855909 @default.
• W2911734644 creator A5048277851 @default.
• W2911734644 creator A5050135968 @default.
• W2911734644 creator A5055535924 @default.
• W2911734644 creator A5082392576 @default.
• W2911734644 creator A5085899733 @default.
• W2911734644 date "2019-01-01" @default.
• W2911734644 modified "2023-10-18" @default.
• W2911734644 title "Improved Control of Secondary Hyperparathyroidism in Hemodialysis Patients Switching from Oral Cinacalcet to Intravenous Etelcalcetide, Especially in Nonadherent Patients" @default.
• W2911734644 doi "https://doi.org/10.1159/000496562" @default.
• W2911734644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30699421" @default.
• W2911734644 hasPublicationYear "2019" @default.
• W2911734644 type Work @default.
• W2911734644 sameAs 2911734644 @default.
• W2911734644 citedByCount "10" @default.
• W2911734644 countsByYear W29117346442019 @default.
• W2911734644 countsByYear W29117346442020 @default.
• W2911734644 countsByYear W29117346442021 @default.
• W2911734644 countsByYear W29117346442022 @default.
• W2911734644 countsByYear W29117346442023 @default.
• W2911734644 crossrefType "journal-article" @default.
• W2911734644 hasAuthorship W2911734644A5005436555 @default.
• W2911734644 hasAuthorship W2911734644A5022120521 @default.
• W2911734644 hasAuthorship W2911734644A5025983976 @default.
• W2911734644 hasAuthorship W2911734644A5032023728 @default.
• W2911734644 hasAuthorship W2911734644A5033938377 @default.
• W2911734644 hasAuthorship W2911734644A5038723740 @default.
• W2911734644 hasAuthorship W2911734644A5041855909 @default.
• W2911734644 hasAuthorship W2911734644A5048277851 @default.
• W2911734644 hasAuthorship W2911734644A5050135968 @default.
• W2911734644 hasAuthorship W2911734644A5055535924 @default.
• W2911734644 hasAuthorship W2911734644A5082392576 @default.
• W2911734644 hasAuthorship W2911734644A5085899733 @default.
• W2911734644 hasConcept C126322002 @default.
• W2911734644 hasConcept C126894567 @default.
• W2911734644 hasConcept C2775945674 @default.
• W2911734644 hasConcept C2778063415 @default.
• W2911734644 hasConcept C2778838027 @default.
• W2911734644 hasConcept C2780280601 @default.
• W2911734644 hasConcept C2780534505 @default.
• W2911734644 hasConcept C2781208988 @default.
• W2911734644 hasConcept C519063684 @default.
• W2911734644 hasConcept C71924100 @default.
• W2911734644 hasConceptScore W2911734644C126322002 @default.
• W2911734644 hasConceptScore W2911734644C126894567 @default.
• W2911734644 hasConceptScore W2911734644C2775945674 @default.
• W2911734644 hasConceptScore W2911734644C2778063415 @default.
• W2911734644 hasConceptScore W2911734644C2778838027 @default.
• W2911734644 hasConceptScore W2911734644C2780280601 @default.
• W2911734644 hasConceptScore W2911734644C2780534505 @default.
• W2911734644 hasConceptScore W2911734644C2781208988 @default.
• W2911734644 hasConceptScore W2911734644C519063684 @default.
• W2911734644 hasConceptScore W2911734644C71924100 @default.
• W2911734644 hasIssue "2" @default.
• W2911734644 hasLocation W29117346441 @default.
• W2911734644 hasLocation W29117346442 @default.
• W2911734644 hasOpenAccess W2911734644 @default.
• W2911734644 hasPrimaryLocation W29117346441 @default.
• W2911734644 hasRelatedWork W1963611706 @default.
• W2911734644 hasRelatedWork W1967923169 @default.
• W2911734644 hasRelatedWork W2029123966 @default.
• W2911734644 hasRelatedWork W2077900736 @default.
• W2911734644 hasRelatedWork W2090885526 @default.
• W2911734644 hasRelatedWork W2114197174 @default.
• W2911734644 hasRelatedWork W2118784283 @default.
• W2911734644 hasRelatedWork W2170610314 @default.
• W2911734644 hasRelatedWork W2401052199 @default.
• W2911734644 hasRelatedWork W3006412573 @default.
• W2911734644 hasVolume "48" @default.
• W2911734644 isParatext "false" @default.
• W2911734644 isRetracted "false" @default.
• W2911734644 magId "2911734644" @default.
• W2911734644 workType "article" @default.